Patents by Inventor Dan OVADYA

Dan OVADYA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230159946
    Abstract: The present invention provides recombinant DNA constructs, vectors and molecules useful for attenuating and/or refining the expression of a florigenic FT gene or transgene using targeting sequences of small RNA molecules. Transgenic plants, plant cells and tissues, and plant parts comprising the recombinant constructs, vectors, and molecules are also provided. Transgenic plants comprising a florigenic FT transgene may produce more bolls, siliques, fruits, nuts, or pods per node on the transgenic plant via suppression, relative to a control or wild type plant. Methods are further provided for introducing the recombinant DNA constructs, vectors, and molecules into a plant, and planting transgenic plants in the field including at higher densities. Transgenic plants of the present invention may provide greater yield potential than wild type or control plants.
    Type: Application
    Filed: November 28, 2022
    Publication date: May 25, 2023
    Applicant: Monsanto Technology LLC
    Inventors: Brent BROWER-TOLAND, Shunhong Dai, Karen Gabbert, Alexander Goldshmidt, Miya Howell, Brad Mcdill, Dan Ovadya, Beth Savidge, Vijay Sharma
  • Patent number: 11555201
    Abstract: The present invention provides recombinant DNA constructs, vectors and molecules useful for attenuating and/or refining the expression of a florigenic FT gene or transgene using targeting sequences of small RNA molecules. Transgenic plants, plant cells and tissues, and plant parts comprising the recombinant constructs, vectors, and molecules are also provided. Transgenic plants comprising a florigenic FT transgene may produce more bolls, siliques, fruits, nuts, or pods per node on the transgenic plant via suppression, relative to a control or wild type plant. Methods are further provided for introducing the recombinant DNA constructs, vectors, and molecules into a plant, and planting transgenic plants in the field including at higher densities. Transgenic plants of the present invention may provide greater yield potential than wild type or control plants.
    Type: Grant
    Filed: October 18, 2017
    Date of Patent: January 17, 2023
    Assignee: Monsanto Technology LLC
    Inventors: Brent Brower-Toland, Shunhong Dai, Karen Gabbert, Alexander Goldshmidt, Miya Howell, Brad McDill, Dan Ovadya, Beth Savidge, Vijay Sharma
  • Publication number: 20180105819
    Abstract: The present invention provides recombinant DNA constructs, vectors and molecules useful for attenuating and/or refining the expression of a florigenic FT gene or transgene using targeting sequences of small RNA molecules. Transgenic plants, plant cells and tissues, and plant parts comprising the recombinant constructs, vectors, and molecules are also provided. Transgenic plants comprising a florigenic FT transgene may produce more bolls, siliques, fruits, nuts, or pods per node on the transgenic plant via suppression, relative to a control or wild type plant. Methods are further provided for introducing the recombinant DNA constructs, vectors, and molecules into a plant, and planting transgenic plants in the field including at higher densities. Transgenic plants of the present invention may provide greater yield potential than wild type or control plants.
    Type: Application
    Filed: October 18, 2017
    Publication date: April 19, 2018
    Inventors: Brent BROWER-TOLAND, Shunhong DAI, Karen GABBERT, Alexander GOLDSHMIDT, Miya HOWELL, Brad MCDILL, Dan OVADYA, Beth SAVIDGE, Vijay SHARMA